SCL
SCL
Stepan CompanyIncome Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $553.89M ▼ | $50.66M ▲ | $5M ▼ | 0.9% ▼ | $0.22 ▼ | $40.53M ▼ |
| Q3-2025 | $590.28M ▼ | $49.23M ▼ | $10.84M ▼ | 1.84% ▼ | $0.47 ▼ | $56.08M ▲ |
| Q2-2025 | $594.69M ▲ | $53.92M ▲ | $11.34M ▼ | 1.91% ▼ | $0.5 ▼ | $49.51M ▼ |
| Q1-2025 | $593.25M ▲ | $47.17M ▼ | $19.71M ▲ | 3.32% ▲ | $0.86 ▲ | $57.81M ▲ |
| Q4-2024 | $525.61M | $49M | $3.35M | 0.64% | $0.15 | $35.59M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $0 ▼ | $2.36B ▼ | $1.11B ▼ | $1.24B ▼ |
| Q3-2025 | $118.54M ▲ | $2.43B ▲ | $1.19B ▲ | $1.25B ▲ |
| Q2-2025 | $88.9M ▼ | $2.42B ▲ | $1.17B ▼ | $1.24B ▲ |
| Q1-2025 | $107.5M ▲ | $2.39B ▲ | $1.19B ▲ | $1.2B ▲ |
| Q4-2024 | $99.67M | $2.3B | $1.13B | $1.17B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $5M ▼ | $59.99M ▼ | $-8.03M ▲ | $-37.7M ▼ | $14.15M ▼ | $-31.1M ▼ |
| Q3-2025 | $10.84M ▼ | $69.76M ▲ | $-29.55M ▼ | $-11M ▼ | $29.63M ▲ | $40.21M ▲ |
| Q2-2025 | $11.34M ▼ | $11.19M ▲ | $-25.06M ▲ | $-9.5M ▼ | $-18.59M ▼ | $-14.4M ▲ |
| Q1-2025 | $19.71M ▲ | $6.94M ▼ | $-26.41M ▲ | $22.76M ▲ | $7.83M ▲ | $-25.81M ▼ |
| Q4-2024 | $3.35M | $68.29M | $-36.2M | $-71.45M | $-47.62M | $32.08M |
Revenue by Products
| Product | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|---|
Polymers | $150.00M ▲ | $160.00M ▲ | $140.00M ▼ | $130.00M ▼ |
Specialty Products | $20.00M ▲ | $20.00M ▲ | $20.00M ▲ | $20.00M ▲ |
Surfactants | $430.00M ▲ | $410.00M ▼ | $420.00M ▲ | $400.00M ▼ |
Revenue by Geography
| Region | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|---|
Asia | $30.00M ▲ | $20.00M ▼ | $30.00M ▲ | $20.00M ▼ |
Europe | $150.00M ▲ | $140.00M ▼ | $130.00M ▼ | $120.00M ▼ |
Latin America | $80.00M ▲ | $90.00M ▲ | $100.00M ▲ | $90.00M ▼ |
North America | $340.00M ▲ | $340.00M ▲ | $330.00M ▼ | $330.00M ▲ |
Q4 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Stepan Company's financial evolution and strategic trajectory over the past five years.
Key strengths include a focused position in specialty surfactants and polymers, strong technical and formulation expertise, and deep, collaborative relationships with a wide range of customers. The company appears to have a solid tangible asset base, moderate leverage, and consistent ability to generate cash from operations. Its innovation agenda, especially around sustainable products and agricultural solutions, aligns well with evolving customer and regulatory demands, reinforcing its role as a value‑added partner rather than just a low‑cost producer.
Main risks center on thin profit margins, capital intensity, and data uncertainty around liquidity. The business is exposed to cyclical end markets, raw material volatility, and strict environmental and safety rules. If demand softens, input costs spike, or new regulations raise compliance burdens, profitability could be pressured given the modest margin structure. Execution risk around large capital projects, efficiency programs, and ongoing product innovation is also significant, as missteps could undermine the benefits of the company’s strong franchise and customer relationships.
Looking ahead, Stepan seems positioned for gradual improvement rather than dramatic transformation, with potential upside from operational efficiency efforts and continued mix shift toward higher‑value, sustainable products. Its diversified end markets and strong cash generation provide a foundation to navigate cycles, but near‑term performance will remain sensitive to macroeconomic conditions and chemical industry dynamics. Given the limitations and inconsistencies in the provided financial data, any forward view should be treated with caution and supplemented with more complete, multi‑year disclosures before drawing firm conclusions.
About Stepan Company
https://www.stepan.comStepan Company, together with its subsidiaries, produces and sells specialty and intermediate chemicals to other manufacturers for use in various end products. It operates through three segments: Surfactants, Polymers, and Specialty Products.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $553.89M ▼ | $50.66M ▲ | $5M ▼ | 0.9% ▼ | $0.22 ▼ | $40.53M ▼ |
| Q3-2025 | $590.28M ▼ | $49.23M ▼ | $10.84M ▼ | 1.84% ▼ | $0.47 ▼ | $56.08M ▲ |
| Q2-2025 | $594.69M ▲ | $53.92M ▲ | $11.34M ▼ | 1.91% ▼ | $0.5 ▼ | $49.51M ▼ |
| Q1-2025 | $593.25M ▲ | $47.17M ▼ | $19.71M ▲ | 3.32% ▲ | $0.86 ▲ | $57.81M ▲ |
| Q4-2024 | $525.61M | $49M | $3.35M | 0.64% | $0.15 | $35.59M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $0 ▼ | $2.36B ▼ | $1.11B ▼ | $1.24B ▼ |
| Q3-2025 | $118.54M ▲ | $2.43B ▲ | $1.19B ▲ | $1.25B ▲ |
| Q2-2025 | $88.9M ▼ | $2.42B ▲ | $1.17B ▼ | $1.24B ▲ |
| Q1-2025 | $107.5M ▲ | $2.39B ▲ | $1.19B ▲ | $1.2B ▲ |
| Q4-2024 | $99.67M | $2.3B | $1.13B | $1.17B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $5M ▼ | $59.99M ▼ | $-8.03M ▲ | $-37.7M ▼ | $14.15M ▼ | $-31.1M ▼ |
| Q3-2025 | $10.84M ▼ | $69.76M ▲ | $-29.55M ▼ | $-11M ▼ | $29.63M ▲ | $40.21M ▲ |
| Q2-2025 | $11.34M ▼ | $11.19M ▲ | $-25.06M ▲ | $-9.5M ▼ | $-18.59M ▼ | $-14.4M ▲ |
| Q1-2025 | $19.71M ▲ | $6.94M ▼ | $-26.41M ▲ | $22.76M ▲ | $7.83M ▲ | $-25.81M ▼ |
| Q4-2024 | $3.35M | $68.29M | $-36.2M | $-71.45M | $-47.62M | $32.08M |
Revenue by Products
| Product | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|---|
Polymers | $150.00M ▲ | $160.00M ▲ | $140.00M ▼ | $130.00M ▼ |
Specialty Products | $20.00M ▲ | $20.00M ▲ | $20.00M ▲ | $20.00M ▲ |
Surfactants | $430.00M ▲ | $410.00M ▼ | $420.00M ▲ | $400.00M ▼ |
Revenue by Geography
| Region | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|---|
Asia | $30.00M ▲ | $20.00M ▼ | $30.00M ▲ | $20.00M ▼ |
Europe | $150.00M ▲ | $140.00M ▼ | $130.00M ▼ | $120.00M ▼ |
Latin America | $80.00M ▲ | $90.00M ▲ | $100.00M ▲ | $90.00M ▼ |
North America | $340.00M ▲ | $340.00M ▲ | $330.00M ▼ | $330.00M ▲ |
Q4 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Stepan Company's financial evolution and strategic trajectory over the past five years.
Key strengths include a focused position in specialty surfactants and polymers, strong technical and formulation expertise, and deep, collaborative relationships with a wide range of customers. The company appears to have a solid tangible asset base, moderate leverage, and consistent ability to generate cash from operations. Its innovation agenda, especially around sustainable products and agricultural solutions, aligns well with evolving customer and regulatory demands, reinforcing its role as a value‑added partner rather than just a low‑cost producer.
Main risks center on thin profit margins, capital intensity, and data uncertainty around liquidity. The business is exposed to cyclical end markets, raw material volatility, and strict environmental and safety rules. If demand softens, input costs spike, or new regulations raise compliance burdens, profitability could be pressured given the modest margin structure. Execution risk around large capital projects, efficiency programs, and ongoing product innovation is also significant, as missteps could undermine the benefits of the company’s strong franchise and customer relationships.
Looking ahead, Stepan seems positioned for gradual improvement rather than dramatic transformation, with potential upside from operational efficiency efforts and continued mix shift toward higher‑value, sustainable products. Its diversified end markets and strong cash generation provide a foundation to navigate cycles, but near‑term performance will remain sensitive to macroeconomic conditions and chemical industry dynamics. Given the limitations and inconsistencies in the provided financial data, any forward view should be treated with caution and supplemented with more complete, multi‑year disclosures before drawing firm conclusions.

CEO
Luis E. Rojo
Compensation Summary
(Year 2024)
Upcoming Earnings
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2012-12-17 | Forward | 2:1 |
| 1994-12-16 | Forward | 2:1 |
ETFs Holding This Stock
Summary
Showing Top 3 of 170
Ratings Snapshot
Rating : B
Most Recent Analyst Grades
Grade Summary
Showing Top 1 of 1
Price Target
Institutional Ownership
BLACKROCK INC.
Shares:3.35M
Value:$170.39M
BLACKROCK, INC.
Shares:3.3M
Value:$168.02M
VANGUARD GROUP INC
Shares:2.57M
Value:$131.04M
Summary
Showing Top 3 of 303

